Unichem Laboratories Ltd share price logo

Unichem Laboratories Ltd

NSE: UNICHEMLAB

BSE: 506690

Small Cap

Pharma Sector

₹524.25

+5.20

(+1.00%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Unichem Laboratories shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-37%

Searches for Unichem Laboratories on INDmoney have decreased by 37% over the last 30 days.

Key Events for Unichem Laboratories

Last Dividend Declared

₹4.00 per share, declared on 27/05/2022

View Dividend History

Unichem Laboratories Stock Performance

as on September 16, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹497.80
    ₹530.10
    downward going graph

    5.05%

    Downside

    1.12%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹278.20
    ₹687.20
    downward going graph

    46.93%

    Downside

    31.08%

    Upside

    downward going graph

Unichem Laboratories share price movements today

Previous Close
₹519.05
Open
₹517.05
Volume
65.50K
Upper Circuit
₹622.85
Lower Circuit
₹415.25
Day's Low - High
₹497.80 - ₹530.10
52 Week Low - High
₹278.20 - ₹687.20

Unichem Laboratories Historical Returns

1 Month Return
-4.46 %
3 Month Return
+ 16.29 %
1 Year Return
+ 2.99 %
3 Year Return
+ 27.05 %
5 Year Return
+ 86.64 %

Unichem Laboratories Fundamentals

as on September 16, 2026 at 4:01 pm IST

Market Cap

₹3,654.41 Cr

Return on Equity (ROE)

-0.61

PE Ratio (TTM)

12.47

Return on capital employed (ROCE)

-0.12

Industry PE ratio

51.81

Beta (LTM)

0.67

P/B Ratio

0.79

Dividend Yield

0

PEG Ratio

0.49

Quarterly Earnings Growth YOY

-496.08

EPS (TTM)

35.91

Book Value

386

Unichem Laboratories Stock Valuation

as on September 16, 2026 at 4:01 pm IST

Unichem Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (-1720.62x)

October 1, 2021

Today (12.47x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (1039.54x)

February 5, 2024

LowHigh

Today’s Price to Earnings Ratio: 12.47x

Unichem Laboratories Technical Analysis

Track how Unichem Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish10
Bullish2
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-0.51
Bearish
CCI (20)
-432.53
Bullish
RSI (14)
43.79
Neutral
Momentum (10)
-1.65
Bullish
ADI (14)
22.74
Neutral
Ultimate Oscillator (7,14,28)
67.7
Neutral

Moving Averages

Name

Value

Action

SMA (20)
523.81
Bearish
EMA (20)
523.71
Bearish
VWMA (20)
523.57
Bearish
SMA (50)
524.82
Bearish
EMA (50)
524.32
Bearish
SMA (200)
523.9
Bearish
EMA (200)
523.74
Bearish
KAMA (200)
525.18
Bearish
DEMA (200)
524.73
Bearish

Unichem Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Unichem Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Unichem Laboratories Ltd image
Unichem Laboratories Ltd
NA3,654.4117.33%0.582522,201
Kobo Biotech Ltd image
Kobo Biotech Ltd
NA10.820.4%0.00-6NA
Sanjivani Paranteral Ltd image
Sanjivani Paranteral Ltd
NA217.8098.2%0.63668
Indoco Remedies Ltd image
Indoco Remedies Ltd
HOLD2,228.12-9.87%0.77-991,845
Venmax Drugs & Pharmaceuticals Ltd image
Venmax Drugs & Pharmaceuticals Ltd
NA21.7125.56%0.00-18
See all

Unichem Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
415.63
465.72
431.7
483.34
507.36
533.09
587.18
526.6
578.96
521.17
575.12
632.62
Other Income
5.54
79.28
6.15
3.76
8.69
13.62
9.25
6.82
20.97
287.32
23.47
15.61
Total Income
421.16
545
437.85
487.1
516.05
546.71
596.43
533.42
599.93
808.49
598.59
648.23
Expenses
406.87
434.6
531.97
443.19
451.87
447.57
503.48
504.11
571.04
476.39
539.8
562.68
Operating Profit
8.76
31.12
-100.27
40.15
55.49
85.52
83.7
22.49
7.92
44.78
35.32
69.94
Operating Profit Margin %
2.11%
6.68%
-23.23%
8.31%
10.94%
16.04%
14.25%
4.27%
1.37%
8.59%
6.14%
11.06%
Profit Before Interest, Tax and Depreciation
14.3
110.4
-94.12
43.91
64.18
99.14
92.95
29.31
28.89
332.1
58.79
85.55
Interest
6.73
5.58
4.59
4.03
4.79
6.75
5.46
6.54
8.24
7.42
9.39
6.62
Depreciation
29.45
31.62
27.16
32.07
32.26
30.54
29.69
31.79
31.47
31.25
30.61
29.94
Profit Before Tax
-21.88
73.2
-125.87
7.81
27.13
61.85
57.8
-9.02
-10.82
293.43
18.79
48.99
Tax Paid
2.6
-0.02
3.44
5.74
2.5
4
4.83
1.45
1.07
29.14
7.88
7.52
Profit After Tax
-24.49
73.22
-129.31
2.07
24.63
57.85
52.97
-10.47
-11.89
264.29
10.91
41.47
Total Net profit including share of profit / Loss from associate company
-24.49
73.22
-129.31
2.07
24.63
57.85
52.97
-10.47
-11.89
264.29
10.91
41.47
EPS
-3.48
10.39
-18.37
0.29
3.5
8.22
7.52
-1.49
-1.69
37.54
1.55
5.89
Actual EPS
-3.48
10.39
-18.37
0.29
3.5
8.22
7.52
-1.49
-1.69
37.54
1.55
5.89
Adjusted EPS
-3.48
10.39
-18.37
0.29
3.5
8.22
7.52
-1.49
-1.69
37.54
1.55
5.89
Diluted EPS
-3.48
10.39
-18.36
0.29
3.49
8.19
7.5
-1.49
-1.69
37.47
1.55
5.89

Unichem Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
814.59
1,180.05
1,103.71
1,235.14
1,269.83
1,343.02
1,785.11
2,110.97
2,201.85
Other Income
2,738.88
100.24
92.13
50.19
47.51
38.52
31.59
35.32
264.92
Total Income
3,553.47
1,280.28
1,195.84
1,285.32
1,317.34
1,381.54
1,816.7
2,146.29
2,466.77
Expenses
946.71
1,263.54
1,154.53
1,144.37
1,198.1
1,427.14
1,755.84
1,846.11
2,017.68
Operating Profit
-132.12
-83.49
-50.82
90.77
71.73
-84.12
29.27
264.86
184.17
Operating Profit Margin %
-16.22%
-7.08%
-4.6%
7.35%
5.65%
-6.26%
1.64%
12.55%
8.36%
Profit Before Interest, Tax and Depreciation
2,606.77
16.74
41.31
140.95
119.24
-45.61
60.86
300.18
449.09
Interest
8.01
7.52
7.85
5.12
6.11
17.31
22.66
21.03
31.59
Depreciation
50.51
67.37
81.67
84.36
91.17
113.44
123.16
124.56
125.12
Profit Before Tax
2,548.25
-58.15
-48.21
51.47
21.96
-176.36
-84.96
154.59
292.38
Tax Paid
3.34
-34.35
11.97
17.15
-11.09
25.86
8.8
17.07
39.54
Profit After Tax
2,544.91
-23.8
-60.18
34.32
33.06
-202.23
-93.76
137.52
252.84
Total Net profit including share of profit / Loss from associate company
2,544.91
-23.8
-60.18
34.32
33.06
-202.23
-93.76
137.52
252.84
EPS
280.6
-3.63
-8.55
4.88
4.7
-28.72
-13.32
19.53
35.91
Actual EPS
280.6
-3.63
-8.55
4.88
4.7
-28.72
-13.32
19.53
35.91
Adjusted EPS
280.6
-3.63
-8.55
4.88
4.7
-28.72
-13.32
19.53
35.91
Diluted EPS
280.41
-3.63
-8.55
4.88
4.68
-28.72
-13.32
19.47
35.85

Unichem Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
111.72
68.19
-112.34
-327.77
19.82
32.98
-259.61
-85.09
14
-7.02
3.64
Cash Flow from Investing Activities
-85.12
-127.87
1,648.34
-286.01
-35.91
-65.97
100.11
240.94
63.31
-241.91
194.4
Cash Flow from Financing Activities
-33.43
59.23
-881.14
-2.42
-62.3
-121.08
191.23
-81.3
-106.31
183.76
1.86
Net Cash Flow
-6.84
-0.46
654.86
-616.19
-78.4
-154.06
31.74
74.56
-29
-65.17
199.9

Unichem Laboratories Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
DII
9.29%
11.27%
11.58%
11.67%
11.63%
11.32%
10.92%
10.75%
10.74%
10.63%
10.46%
FII
0%
0.9%
0.89%
0.94%
1.06%
0.98%
0.98%
1%
0.99%
1%
0.91%
Public
18.18%
17.61%
17.3%
17.18%
17.09%
17.48%
17.88%
18.03%
18.05%
18.15%
18.42%
Total Outstanding Shares
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
Total Shareholders
20,877
21,171
20,621
20,374
21,472
21,621
23,010
23,577
23,267
23,386
25,347

Mutual Funds Buying / Exiting Unichem Laboratories

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Unichem Laboratories

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

DSP Healthcare Fund Direct Growth

DSP Healthcare Fund Direct Growth

₹59.17 Cr

₹0.21 Cr (+0.36%)

1.64%

Bandhan BSE Healthcare Index Fund Direct Growth

Bandhan BSE Healthcare Index Fund Direct Growth

₹0.02 Cr

₹0.00 Cr (+6.07%)

0.07%

Mutual Funds Exiting Unichem Laboratories

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Unichem Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Unichem Laboratories.

  • Unichem Laboratories Ltd Earnings Results

    Unichem Laboratories Ltd’s net profit jumped 496.08% since last year same period to ₹41.47Cr in the Q1 2026-2027. On a quarterly growth basis, Unichem Laboratories Ltd has generated 280.11% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Unichem Laboratories Ltd Dividends May,2022

    In the quarter ending March 2022, Unichem Laboratories Ltd has declared dividend of ₹4.00 per share on 27 May 2022 - translating a dividend yield of 1.54%.

    Read More about Dividends

Indices Featuring Unichem Laboratories Stock

Check stock indices that include Unichem Laboratories.

BSE Healthcare

₹50,434.00

-44.81 (▲0.09%)

Insights on Unichem Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, UNICHEMLAB stock has moved up by 68.1%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 10.91 Cr → 41.47 Cr (in ₹), with an average increase of 73.7% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 18.15% to 18.42% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 598.59 Cr → 648.23 Cr (in ₹), with an average increase of 7.7% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 9.07% to 9.32% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 47.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 130.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.22% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.00% to 0.90% in Jun 2026 quarter

About Unichem Laboratories Ltd

Unichem Laboratories Ltd is an India based pharmaceutical company, headquartered in Mumbai, specialising in the manufacture of active pharmaceutical ingredients (API). Founded in 1962, the company has five manufacturing facilities in Roha, Maharashtra; Goa; Ghaziabad, Uttar Pradesh; Pithampur, Madhya Pradesh; and Baddi, Himachal Pradesh, all of which have been certified ISO 9001:2000 and ISO 14001:2004. Over the years, Unichem Laboratories Ltd has formed collaborations and acquired subsidiaries such as Uni Sankyo Co.Marketing Formulations, Medical Corporation South Africa, Unisearch Ltd., Niche Generics Ltd., and Unichem Pharmaceuticals USA Inc. In 2019, they set up their first subsidiary in China, Younikaimo Pharmaceutical Shanghai Private Limited. The company recently sold their domestic formulations business, and manufacturing facility at Sikkim, on a going concern basis, to Torrent Pharmaceuticals Limited. They remain at the forefront of the pharmaceutical industry with their commitment to innovation and quality.

Revenue: ₹632.62Cr as on June 2026 (Q1 FY27)
Net Profit: ₹41.47Cr as on June 2026 (Q1 FY27)
Listing date: 10 Jan, 1995
Chairperson Name: Prakash A Mody
OrganisationUnichem Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOPrakash A Mody
E-voting on sharesClick here to vote

FAQs

What is Unichem Laboratories share price today?

Unichem Laboratories share price today stands at ₹524.25 as on at the close of the market. Unichem Laboratories share today touched a day high of ₹530.1 and a low of ₹497.8.

What is the 52 week high and 52 week low range for Unichem Laboratories share?

Unichem Laboratories touched a 52 week high of ₹687.2 and a 52 week low of ₹278.2. Unichem Laboratories share price today i.e. is closed at ₹524.25, which is -23.71% down from its 52 week high and 88.44% up from its 52 week low.

What is Unichem Laboratories's market capitalisation today?

Unichem Laboratories market capitalisation is ₹3,654.41 Cr as on .

How to buy Unichem Laboratories shares?

To buy Unichem Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for UNICHEMLAB or Unichem Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Unichem Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Unichem Laboratories trading volume today?

Unichem Laboratories trading volume is 65.50K as on . This means that 65.50K shares of Unichem Laboratories were bought and sold on the stock market during today's trading session.